Granules India Hits New Milestone with Record High Stock Price

Granules India, a midcap pharmaceutical company, has recently reached a new milestone as its stock price touched a 52-week high on July 24, 2024. The stock has been performing well in the market, with a 'Hold' recommendation from MarketsMOJO. On July 24, the stock hit a high of Rs. 531.7, which is not only a new 52-week high but also an all-time high for the company. It has also outperformed the sector by 1.15% on the same day. This marks the third consecutive day of gains for Granules India, with a 6.16% increase in its stock price during this period. In terms of moving averages, Granules India is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend in the stock's performance. When compared to the Sensex, Granules India has shown a remarkable 74.01% growth in the past year, while the Sensex has only grown by 21.15%. This showcases the company's strong performance and potential for growth in the pharmaceutical industry. Granules India is a midcap company in the pharma sector, known for its high-quality products and strong presence in both domestic and international markets. With its recent achievements and positive market performance, the company is poised for further success in the future.